Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-transplantation Cyclophosphamide in MDS HCT
NCT02969980Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- Nov 2016
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in graft-versus-host disease (GVHD), sponsored by Asan Medical Center. Started Nov 2016; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT02969980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02969980.